Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuli Qu

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Clinical Therapeutics|September 14, 2019
Comparison of Characteristics Between Chinese Patients Taking Glucagon-like Peptide 1 Receptor Agonists and Insulin: A Cross-sectional Database AnalysisKe Wang, Yun Chen, Alena Strizek, et al.
Future Oncology (London, England)|March 21, 2022
Indirect comparison of sintilimab and other PD-L1 inhibitors for first-line treatment of non-squamous non-small-cell lung cancerLei Zhang, Yijiao Qian, Jinnan Li, et al.
BMC Psychiatry|September 7, 2018
Comparative efficacy and safety between amisulpride and olanzapine in schizophrenia treatment and a cost analysis in China: a systematic review, meta-analysis, and cost-minimization analysisPeng Men, Zhanmiao Yi, Chaoyun Li, et al.
Risk Management and Healthcare Policy|June 3, 2024
Recombinant Human Follicle-Stimulating Hormone in Controlled Ovarian Hyperstimulation with Assisted Reproductive Technology in China: A Cost-Effectiveness AnalysisHongchao Li, Wei He, Hongbo Lin, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 24, 2021
Cost-Effectiveness of Flash Glucose Monitoring for the Management of Patients with Type 1 and Patients with Type 2 Diabetes in ChinaXinran Zhao, Jian Ming, Shuli Qu, et al.
Annals of Internal Medicine|July 14, 2015
Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task ForceRui Li, Shuli Qu, Ping Zhang, et al.
The Journal of Mental Health Policy and Economics|April 12, 2015
Legislations and policies to expand mental health and substance abuse benefits in health insurance plans: a community guide systematic economic reviewVerughese Jacob, Shuli Qu, Sajal Chattopadhyay, et al.
Current Therapeutic Research, Clinical and Experimental|December 17, 2021
Prostate Cancer Screening Using Prostate-Specific Antigen Tests in a High-Risk Population in China: A Cost-Utility AnalysisXiaojian Qin, Dingwei Ye, Chengyuan Gu, et al.
NPJ Primary Care Respiratory Medicine|May 21, 2021
Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in ChinaShuli Qu, Xuedan You, Tianyi Liu, et al.
Value in Health Regional Issues|November 13, 2018
Assessing the Burden of Type 2 Diabetes in China Considering the Current Status-Quo Management and Implications of Improved Management Using a Modeling ApproachVolker Foos, Ke Wang, Phil McEwan, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Clinical Therapeutics|September 14, 2019
Comparison of Characteristics Between Chinese Patients Taking Glucagon-like Peptide 1 Receptor Agonists and Insulin: A Cross-sectional Database AnalysisKe Wang, Yun Chen, Alena Strizek, et al.
Future Oncology (London, England)|March 21, 2022
Indirect comparison of sintilimab and other PD-L1 inhibitors for first-line treatment of non-squamous non-small-cell lung cancerLei Zhang, Yijiao Qian, Jinnan Li, et al.
BMC Psychiatry|September 7, 2018
Comparative efficacy and safety between amisulpride and olanzapine in schizophrenia treatment and a cost analysis in China: a systematic review, meta-analysis, and cost-minimization analysisPeng Men, Zhanmiao Yi, Chaoyun Li, et al.
Risk Management and Healthcare Policy|June 3, 2024
Recombinant Human Follicle-Stimulating Hormone in Controlled Ovarian Hyperstimulation with Assisted Reproductive Technology in China: A Cost-Effectiveness AnalysisHongchao Li, Wei He, Hongbo Lin, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 24, 2021
Cost-Effectiveness of Flash Glucose Monitoring for the Management of Patients with Type 1 and Patients with Type 2 Diabetes in ChinaXinran Zhao, Jian Ming, Shuli Qu, et al.
Annals of Internal Medicine|July 14, 2015
Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task ForceRui Li, Shuli Qu, Ping Zhang, et al.
The Journal of Mental Health Policy and Economics|April 12, 2015
Legislations and policies to expand mental health and substance abuse benefits in health insurance plans: a community guide systematic economic reviewVerughese Jacob, Shuli Qu, Sajal Chattopadhyay, et al.
Current Therapeutic Research, Clinical and Experimental|December 17, 2021
Prostate Cancer Screening Using Prostate-Specific Antigen Tests in a High-Risk Population in China: A Cost-Utility AnalysisXiaojian Qin, Dingwei Ye, Chengyuan Gu, et al.
NPJ Primary Care Respiratory Medicine|May 21, 2021
Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in ChinaShuli Qu, Xuedan You, Tianyi Liu, et al.
Value in Health Regional Issues|November 13, 2018
Assessing the Burden of Type 2 Diabetes in China Considering the Current Status-Quo Management and Implications of Improved Management Using a Modeling ApproachVolker Foos, Ke Wang, Phil McEwan, et al.
Pageof 3